Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01719822|
Recruitment Status : Completed
First Posted : November 1, 2012
Last Update Posted : May 13, 2015
|Condition or disease||Intervention/treatment|
|Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive Bronchitis, Chronic||Device: Yamax Digi-Walker CW-700|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||155 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Primary Purpose:||Supportive Care|
|Official Title:||Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease|
|Study Start Date :||July 2012|
|Primary Completion Date :||February 2015|
|Study Completion Date :||February 2015|
No Intervention: Usual Care
Standard 8-week pulmonary rehabilitation programme with 2 supervised sessions per week and a written home exercise plan/diary.
Standard 8-week pulmonary rehabilitation programme with 2 supervised sessions per week. In addition they will receive a pedometer with a daily step count target set by a physiotherapist and a written home exercise plan/diary.
Device: Yamax Digi-Walker CW-700
A pedometer with a daily step count target set by a physiotherapist.
- Change from baseline of time spent in at least moderate physical activity (3>METS equivalent) [ Time Frame: 8 weeks ]
- Change from baseline of Incremental Shuttle Walk [ Time Frame: 8 weeks ]
- Change from baseline of Chronic Respiratory Disease Questionaire (CRDQ) [ Time Frame: 8 weeks ]
- Change from baseline of Medical Outcomes Survey Short Form 36 item questionaire SF-36 [ Time Frame: 8 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01719822
|Middlesex, United Kingdom, UB9 6JH|
|Principal Investigator:||William DC Man, MRCP, PhD||Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College London|